It will take a ‘few years’ for Sun Pharma to realise the benefits of its $4 billion takeover of Ranbaxy, said the company's Chairman Israel Makov, terming the deal as a ‘complex......
Sun Pharma’s recent purchase of ailing Ranbaxy Laboratories might have come as a surprise but analysts said the deal was in sync with the character of Mumbai-headquartered drug maker, known......